Fidelity Investments’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,629
| Closed | -$22.1K | – | 5476 |
|
|
2025
Q1 | $22.1K | Buy |
12,629
+7,073
| +127% | +$12.4K | ﹤0.01% | 4190 |
|
|
2024
Q4 | $8.78K | Sell |
5,556
-322,601
| -98% | -$510K | ﹤0.01% | 4510 |
|
|
2024
Q3 | $515K | Sell |
328,157
-1,694,443
| -84% | -$2.66M | ﹤0.01% | 2837 |
|
|
2024
Q2 | $3.61M | Sell |
2,022,600
-900,000
| -31% | -$1.61M | ﹤0.01% | 2176 |
|
|
2024
Q1 | $8.42M | Hold |
2,922,600
| – | – | ﹤0.01% | 1927 |
|
|
2023
Q4 | $3.74M | Hold |
2,922,600
| – | – | ﹤0.01% | 2139 |
|
|
2023
Q3 | $4.03M | Buy |
2,922,600
+716,000
| +32% | +$988K | ﹤0.01% | 2103 |
|
|
2023
Q2 | $3.24M | Buy |
2,206,600
+11,600
| +0.5% | +$17.1K | ﹤0.01% | 2185 |
|
|
2023
Q1 | $1.86M | Hold |
2,195,000
| – | – | ﹤0.01% | 2382 |
|
|
2022
Q4 | $3.01M | Hold |
2,195,000
| – | – | ﹤0.01% | 2262 |
|
|
2022
Q3 | $3.73M | Buy |
+2,195,000
| New | +$3.73M | ﹤0.01% | 2251 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5401 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5402 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4843 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4919 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4767 |
|
|
2018
Q4 | – | Sell |
-33,010
| Closed | -$783K | – | 4048 |
|
|
2018
Q3 | $783K | Sell |
33,010
-97,389
| -75% | -$2.31M | ﹤0.01% | 2501 |
|
|
2018
Q2 | $10.3M | Buy |
130,399
+450
| +0.3% | +$35.6K | ﹤0.01% | 1934 |
|
|
2018
Q1 | $11.2M | Buy |
129,949
+5
| +0% | +$431 | ﹤0.01% | 1933 |
|
|
2017
Q4 | $16.2M | Buy |
129,944
+212
| +0.2% | +$26.5K | ﹤0.01% | 1800 |
|
|
2017
Q3 | $19.5M | Buy |
129,732
+63,254
| +95% | +$9.49M | ﹤0.01% | 1705 |
|
|
2017
Q2 | $7.86M | Buy |
66,478
+312
| +0.5% | +$36.9K | ﹤0.01% | 2028 |
|
|
2017
Q1 | $13.1M | Buy |
66,166
+12
| +0% | +$2.38K | ﹤0.01% | 1858 |
|
|
2016
Q4 | $17.9M | Buy |
66,154
+129
| +0.2% | +$34.8K | ﹤0.01% | 1720 |
|
|
2016
Q3 | $26.1M | Buy |
66,025
+49
| +0.1% | +$19.4K | ﹤0.01% | 1559 |
|
|
2016
Q2 | $22.9M | Buy |
65,976
+95
| +0.1% | +$32.9K | ﹤0.01% | 1611 |
|
|
2016
Q1 | $54.8M | Buy |
65,881
+453
| +0.7% | +$377K | 0.01% | 1213 |
|
|
2015
Q4 | $68.5M | Buy |
65,428
+529
| +0.8% | +$554K | 0.01% | 1130 |
|
|
2015
Q3 | $50.9M | Buy |
64,899
+1,127
| +2% | +$884K | 0.01% | 1239 |
|
|
2015
Q2 | $83.9M | Buy |
63,772
+626
| +1% | +$823K | 0.01% | 1118 |
|
|
2015
Q1 | $128M | Buy |
63,146
+2,391
| +4% | +$4.86M | 0.02% | 916 |
|
|
2014
Q4 | $117M | Buy |
60,755
+6,515
| +12% | +$12.5M | 0.02% | 926 |
|
|
2014
Q3 | $44.5M | Buy |
54,240
+1,597
| +3% | +$1.31M | 0.01% | 1352 |
|
|
2014
Q2 | $50.8M | Buy |
52,643
+23
| +0% | +$22.2K | 0.01% | 1328 |
|
|
2014
Q1 | $57M | Buy |
52,620
+398
| +0.8% | +$431K | 0.01% | 1263 |
|
|
2013
Q4 | $46.3M | Buy |
52,222
+1,158
| +2% | +$1.03M | 0.01% | 1352 |
|
|
2013
Q3 | $57.8M | Buy |
51,064
+18,485
| +57% | +$20.9M | 0.01% | 1206 |
|
|
2013
Q2 | $38.4M | Buy |
+32,579
| New | +$38.4M | 0.01% | 1368 |
|